Post a Free Blog

Submit A Press Release

Friday, March 29, 2024
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Truck Series (TRUCK)
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
-- Advertisement --spot_img
HomeBusinessAstraZeneca Error In COVID-19 Trials May Halt FDA Approval

AstraZeneca Error In COVID-19 Trials May Halt FDA Approval

 

 

AstraZeneca has admitted that a mistake had been made in the coronavirus trials conducted by the company. This has caused a certain amount of confusion as well as a drop in its share prices as reports say that this may hamper its FDA early approval.

 

AstraZeneca had created waves initially by saying that its vaccine would be much cheaper than the ones developed by Pfizer and Moderna as well as it would be easier to store.

 

However the UK pharmaceutical company, along with its partner Oxford University, said that a mistake had been made. After getting 90% positive results, they realized that a batch of the volunteers had been given half doses but showed better results than the main group of volunteers who were given the correct two doses but showed 62% efficacy.

 

Natalie Dean, a biostatistician and expert in vaccine trial design from the University of Florida wrote, “It is awfully confusing for experts and non experts alike.” She gave Team UK vaccine “a poor grade for transparency and rigor,” on Twitter.

 

Analysts and scientists alike have been disappointed with the handling of the issue as well as the mistake though the lead researcher at AstraZeneca called it “serendipity.”

 

A spokesperson for AstraZeneca Michele Meixell said that the trials were conducted “to the highest standard,” and added that more analysis is being carried out to refine the efficacy results.

 

Source NY Post NY Times

Subscribe to get Latest News Updates

Latest News Articles

You may like more
more

Walgreens Boots Alliance Shares Gains 3 percent Following Q2 Results

Walgreens Boots Alliance (NASDAQ:WBA) shares rose more than 3%...

Home Depot to Buy SRS Distribution

Home Depot (NYSE:HD) announced its intention to purchase SRS...

Google code on Pinterest app suggests potential test of ad units, CWEB analysts say

Google and Pinterest might be testing a new partnership....

DraftKings Falls, NCAA Wants to Ban College Prop Bets. CWEB analysts issue Hold Rating on the stock.

Shares of DraftKings Inc.(DKNG) experienced a significant decline on...